Zobrazeno 1 - 10
of 964
pro vyhledávání: '"Novellasdemunt L"'
Autor:
Powell GT; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK., Faro A; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK., Zhao Y; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK., Stickney H; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.; Departments of Otolaryngology-HNS and Biological Structure, University of Washington, Seattle, WA 98195-7420, USA.; Ambry Genetics, Aliso Viejo, CA 92656, USA., Novellasdemunt L; The Francis Crick Institute, London, NW1 1AT, UK.; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain., Henriques P; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK., Gestri G; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK., Redhouse White E; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK., Ren J; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK., Lu W; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK., Young RM; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.; Institute of Ophthalmology, University College London, London EC1V 9EL, UK.; Center for Integrative Biology, Facultad de Ciencias, Universidad Mayor, Camino La Piramide 5750, 8580745 Santiago, Chile., Hawkins TA; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK., Cavodeassi F; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.; St. George's, University of London, London SW17 0RE, UK., Schwarz Q; Institute of Ophthalmology, University College London, London EC1V 9EL, UK., Dreosti E; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK., Raible DW; Departments of Otolaryngology-HNS and Biological Structure, University of Washington, Seattle, WA 98195-7420, USA., Li VSW; The Francis Crick Institute, London, NW1 1AT, UK., Wright GJ; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK.; Department of Biology, Hull York Medical School, York Biomedical Research Institute, University of York, York YO10 5DD, UK., Jones EY; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK., Wilson SW; Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 May 03; Vol. 384 (6695), pp. 573-579. Date of Electronic Publication: 2024 May 02.
Autor:
Novellasdemunt L; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Kucharska A; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Baulies A; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Hutton C; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Vlachogiannis G; Centre for Molecular Pathology, the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK., Repana D; Cancer Systems Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Suárez-Bonnet A; Pathobiology and Population Sciences, Royal Veterinary College, Hatfield AL9 7TA, UK; Experimental Histopathology, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Ciccarelli F; Cancer Systems Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Valeri N; Centre for Molecular Pathology, the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK., Li VSW; Stem Cell and Cancer Biology Laboratory, the Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: vivian.li@crick.ac.uk.
Publikováno v:
Stem cell reports [Stem Cell Reports] 2023 Feb 14; Vol. 18 (2), pp. 570-584. Date of Electronic Publication: 2023 Jan 19.
Autor:
Cañellas-Socias A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Cortina C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Hernando-Momblona X; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Palomo-Ponce S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Mulholland EJ; Gastrointestinal Stem Cell Biology Lab, Wellcome Centre Human Genetics, University of Oxford, Oxford, UK., Turon G; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Mateo L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Conti S; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Roman O; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Sevillano M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Slebe F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Stork D; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Caballé-Mestres A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Berenguer-Llergo A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Álvarez-Varela A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Fenderico N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Novellasdemunt L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Jiménez-Gracia L; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Sipka T; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Bardia L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Lorden P; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Colombelli J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Heyn H; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Trepat X; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Tejpar S; Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium., Sancho E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Tauriello DVF; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Leedham S; Gastrointestinal Stem Cell Biology Lab, Wellcome Centre Human Genetics, University of Oxford, Oxford, UK.; Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Oxford National Institute for Health Research Biomedical Research Centre, Oxford, UK., Attolini CS; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Batlle E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. eduard.batlle@irbbarcelona.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain. eduard.batlle@irbbarcelona.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. eduard.batlle@irbbarcelona.org.
Publikováno v:
Nature [Nature] 2022 Nov; Vol. 611 (7936), pp. 603-613. Date of Electronic Publication: 2022 Nov 09.
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy.
Autor:
Álvarez-Varela A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Novellasdemunt L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Barriga FM; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hernando-Momblona X; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Cañellas-Socias A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Cano-Crespo S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Sevillano M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Cortina C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Stork D; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Morral C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Turon G; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Slebe F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Jiménez-Gracia L; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Caratù G; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Jung P; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Munich, Institute of Pathology, Ludwig Maximilian University, Munich, Germany., Stassi G; Department of Surgical Oncological and Stomatological Sciences, University of Palermo, Palermo, Italy., Heyn H; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Tauriello DVF; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Mateo L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Tejpar S; Molecular Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium., Sancho E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Stephan-Otto Attolini C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Batlle E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. eduard.batlle@irbbarcelona.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain. eduard.batlle@irbbarcelona.org.; ICREA, Barcelona, Spain. eduard.batlle@irbbarcelona.org.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1052-1070. Date of Electronic Publication: 2022 Jun 30.
Autor:
Sánchez-Botet A; Department of Basic Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Josep Trueta, s/n, 08195, Sant Cugat del Vallès, Barcelona, Spain., Quandt E; Department of Basic Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Josep Trueta, s/n, 08195, Sant Cugat del Vallès, Barcelona, Spain., Masip N; Department of Basic Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Josep Trueta, s/n, 08195, Sant Cugat del Vallès, Barcelona, Spain., Escribá R; Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), L'Hospitalet del Llobregat, Barcelona, Spain.; Centre for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain., Novellasdemunt L; Stem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, UK., Gasa L; Department of Basic Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Josep Trueta, s/n, 08195, Sant Cugat del Vallès, Barcelona, Spain., Li VSW; Stem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, UK., Raya Á; Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), L'Hospitalet del Llobregat, Barcelona, Spain.; Centre for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain., Clotet J; Department of Basic Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Josep Trueta, s/n, 08195, Sant Cugat del Vallès, Barcelona, Spain. jclotet@uic.es., Ribeiro MPC; Department of Basic Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Josep Trueta, s/n, 08195, Sant Cugat del Vallès, Barcelona, Spain. mpontecardosoribeiro@uic.es.
Publikováno v:
Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2021 Dec; Vol. 44 (6), pp. 1273-1286. Date of Electronic Publication: 2021 Oct 04.
Autor:
Tajan M; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Hennequart M; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Cheung EC; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Zani F; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Hock AK; Cancer Research UK Beatson Institute, Switchback Road, Glasgow, G61 1BD, UK.; Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Legrave N; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Maddocks ODK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK., Ridgway RA; Cancer Research UK Beatson Institute, Switchback Road, Glasgow, G61 1BD, UK., Athineos D; Cancer Research UK Beatson Institute, Switchback Road, Glasgow, G61 1BD, UK., Suárez-Bonnet A; The Royal Veterinary College, Hawkshead Lane, Harfield, Herts, AL9 7TA, UK., Ludwig RL; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Novellasdemunt L; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Angelis N; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Li VSW; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Vlachogiannis G; Gastrointestinal Cancer Biology and Genomics Team, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK., Valeri N; Gastrointestinal Cancer Biology and Genomics Team, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Mainolfi N; Raze Therapeutics, Inc., Cambridge, MA, USA., Suri V; Raze Therapeutics, Inc., Cambridge, MA, USA., Friedman A; Raze Therapeutics, Inc., Cambridge, MA, USA., Manfredi M; Raze Therapeutics, Inc., Cambridge, MA, USA., Blyth K; Cancer Research UK Beatson Institute, Switchback Road, Glasgow, G61 1BD, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK., Sansom OJ; Cancer Research UK Beatson Institute, Switchback Road, Glasgow, G61 1BD, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK., Vousden KH; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK. karen.vousden@crick.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Jan 14; Vol. 12 (1), pp. 366. Date of Electronic Publication: 2021 Jan 14.
Autor:
Nakka, Parvathi1 (AUTHOR), Jassi, Chikondi2 (AUTHOR), Chen, Ming-Cheng3,4 (AUTHOR), Liu, Yi-Sheng5,6 (AUTHOR), Liu, Jer-Yuh1,7 (AUTHOR), Yeh, Chung-Min8 (AUTHOR), Li, Chi-Cheng9,10 (AUTHOR), Chang, Yu-Chun11 (AUTHOR), Kuo, Wei-Wen2,12 (AUTHOR), Huang, Chih-Yang1,11,13,14,15 (AUTHOR) cyhuang@mail.cmu.edu.tw
Publikováno v:
Cancer Cell International. 8/16/2024, Vol. 24 Issue 1, p1-12. 12p.
Autor:
Nie, Junyu1 (AUTHOR) njy@ntu.edu.cn, Chen, Hao1 (AUTHOR), Zhao, Xiuling1 (AUTHOR) zhaoxiuling@ntu.edu.cn
Publikováno v:
Biomolecules (2218-273X). Aug2024, Vol. 14 Issue 8, p1026. 13p.
Autor:
Shi, Wen1,2 (AUTHOR) wshi@cmu.edu.cn, Zhang, Zhe3 (AUTHOR) 20181074@cmu.edu.cn, Wang, Xiaohong1 (AUTHOR) wangxiaohong@cmu.edu.cn
Publikováno v:
Biomolecules (2218-273X). Aug2024, Vol. 14 Issue 8, p1019. 24p.
Publikováno v:
China Oncology. Aug2024, Vol. 34 Issue 8, p763-776. 14p.